Related references
Note: Only part of the references are listed.Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study
Aslaug Johanne Risoy et al.
PLOS ONE (2018)
Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study
Narjis Fikri-Benbrahim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Point-of-care screenings at the University of Minnesota: Mechanism for civic engagement
Laura C. Palombi et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2014)
The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting
Andrew Willis et al.
PLOS ONE (2014)
Establishing a cardiovascular health and wellness program in a community pharmacy: Screening for metabolic syndrome
Julie L. Olenak et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2010)
Development and Validation of a Patient Self-assessment Score for Diabetes Risk
Heejung Bang et al.
ANNALS OF INTERNAL MEDICINE (2009)
Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy
I. Krass et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals
Kathleen A. Snella et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2006)